Table 2.

Description of participants clinical characteristics

	Frequency (%)
Clinical staging for psychotic
Stage 3b :Recurrence or relapse of psychotic	68 (43.0%)
Stage 3c :Multiple relapses	75 (47.5%)
Stage 4 :Severe, persistent, or unremitting illness	15 (9.5%)
Clinical Global Impressions (CGI)
Mildly ill	46 (29.1%)
Moderately ill	58 (36.7%)
Markedly ill	39 (24.7%)
Severely ill	15 (9.5%)
	Mean ± SD
Total PANSS scale	59.68 ± 16.56 (Median = 56; IQR = 21)
Positive PANSS subscale	16.94 ± 5.56
Negative PANSS subscale	15.68 ± 6.52
General psychopathology PANSS subscale	27.05 ± 7.37 (Median = 25; IQR = 8)
Depression (MADRS scale)	2.47 ± 3.85 (Median = 0.001; IQR = 4)
Manic symptoms (YMRS scale)	4.80 ± 3.27
Global Assessment of Functioning (GAF scale)	36.83 ± 7.30
Chlorpromazine equivalent dose	1179.69 ± 1024.12
Number of antipsychotic treatment	1.84 ± 0.84